Results 171 to 180 of about 56,017 (267)

Spatial and single‐nuclei transcriptomics reveals idiosyncratic and generic patterns in papillary and anaplastic thyroid cancers

Molecular Oncology, EarlyView.
Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur, Joel Rodrigues Vitória, Manuel Saiselet, Ligia Craciun, Denis Larsimont, Anne Lefort, Frédérick Libert, Carine Maenhaut, Sabine Costagliola, Maxime Tarabichi, Mirian Romitti, Vincent Detours   +11 more
wiley   +1 more source

Prise en charge de la multimorbidité cœur–cerveau : un guide de pratique clinique. [PDF]

CMAJ
Edwards JD, Li Z, McFarlane P, Rabi DM, Gilbert J, Bajaj HS, MacIntosh BJ, Bittman J, Feldman RD, Dresser G, Terenzi K, Swartz R, Gabor J, Pearson GJ, Selby P, Wharton S, Warburton DER, Pakhalé S, Styra R, Baker B, Tu K, Hawkins M, Stone JA, Vaillancourt T, Poon S, Virani SA, Jain R, Jones PH, Sandhu RK, Ganesh A, Andrade JG, Stern S, Habert J, Rivard L, Roumeliotis P, Udell JA, Campbell T, Bacon SL, Trudeau L, Keshavjee K, Pham T, Cheng G, Lewis KB, Maar M, Stacey D, Oldenburg B, Dhukai AR, Pasricha SV, Sherifali D, Racey M, Hua-Stewart D, Gravel CA, Lewis M, Mehta S, Hill MD, Haider N, Lindsay P, Liu P, Tobe SW.   +58 more
europepmc   +1 more source

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

Molecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington, Divya L. Dayanidhi, Mohammad Zokaasadi, John B. Mantyh, Pelumi D. Olawuni, Gabrielle Rupprecht, Jeremy M. Force, Shannon McCall, Ashwani K. Bahl, David S. Hsu, Jason A. Somarelli   +10 more
wiley   +1 more source

Evaluation of a collaborative care system in primary care in the implementation of ambulatory follow-up in mental health: A study protocol. [PDF]

PLoS One
Dias Alves M, Jobic A, Rosso N, Abello M, Autret A, Vion-Dury J, Belzeaux R, Korrichi F.   +7 more
europepmc   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

Molecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq, Marc Terrones, Felicia Rodrigues Fortes, Anne Schepers, Alessia Denis, Christophe Deben, Ken Op de Beeck, Guy Van Camp, Geert Vandeweyer   +8 more
wiley   +1 more source

Single-nucleus RNA sequencing identifies conserved structural cell programs in allergic lung inflammation. [PDF]

J Allergy Clin Immunol Glob
Govindhan A, Sur A, Hosoki K, Sur S.
europepmc   +1 more source

Sur quelques formules du calcul de Ricci global

Commentarii Mathematici Helvetici, 1966
openaire   +2 more sources

Sur l'anneau des fonctions de Nash globales [PDF]

Annales scientifiques de l'École normale supérieure, 1975
openaire   +2 more sources

ZW4864‐mediated inhibition of the β‐catenin/BCL9/BCL9L complex reveals therapeutic potential in bladder cancer

Molecular Oncology, EarlyView.
BCL9 and BCL9L drive bladder cancer progression by enhancing β‐catenin signaling, promoting proliferation, migration, invasion, and organoid growth. Genetic depletion of BCL9(L) suppresses malignant phenotypes, while pharmacological disruption of the β‐catenin/BCL9(L) complex with ZW4864 inhibits canonical Wnt signaling and tumor‐associated cellular ...
Roland Kotolloshi, Mandy Berndt‐Paetz, Eileen Lerner, Gregoire Najjar, Anca Azoitei, Krishna Pal Singh, Shailendra Kumar Gupta, Olaf Wolkenhauer, Cagatay Günes, Otmar Huber, Marc‐Oliver Grimm, Daniel Steinbach   +11 more
wiley   +1 more source

Should they stay or should they go? Regulating microRNA turnover in plants. [PDF]

Plant Cell
Traubenik S.
europepmc   +1 more source